Navigation Links
High development costs hinder entry of cancer super drugs into the market

Cancer patients in the future could benefit from pharmacogenomics or the field of personalized medicine where therapies could be tailored to suit individual patients. Few drugs which target specific protein receptors in cancer are already in the market and the decoding of the human genome// offers great promise to patients, as the therapy could become more specialized. However, all this comes with a heavy cost and cancer research experts warn that such breakthroughs may not lead to new treatment due to the cost.

Pharmaceutical companies face formidable problems in this new treatment approach as it costs about $100 million to develop a cancer drug and only about one in ten make it to the market. The developmental costs of these drugs are so high because they are targeted at specific molecules and this requires sophisticated screening tests.

The pharma companies are already pulling out of oncology drugs since the potential market is too small, as the patients treated with a particular drug are confined to a small genetically defined subgroup, and the sales from this small group would not cover the development costs. Unless scientists are able to show that these drugs work on a specific genetic type instead of on only 2 or 3 per cent of patients, these drugs may not make it to the market.

A cancer research expert, Dr. Keith Snell warned that if development costs are not reduced, the new cancer therapies have very slim chances of reaching the cancer patients. He however suggested that the solution lies in simplifying clinical trials and small biotechnology companies, major drug companies and scientific researchers agreeing to share the risks, thereby making the development process a more economic proposition.


'"/>




Page: 1

Related medicine news :

1. Cancer drugs in development nearly doubled since 1995
2. Role of zinc in development
3. Particulate matter affects lung development
4. Fossil teeth and human development
5. Fireflies help speed development of new drugs
6. AEternas acquisition of Zentaris being followed up with its new product pipeline and clinical development strategy
7. New fertility drug development techniques by Organon
8. Biosensor chip to help drug development
9. Cells critical for asthma development found
10. ICMR along with other International Research organisation with drug development for Neglected Diseases
11. Epilepsy surgery to help child development
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/4/2016)... Boca Raton, Fl (PRWEB) , ... December 02, ... ... a partnership that will give patients better access to nutraceuticals and help doctors ... to their EMR patient portal and practice management software platform for Integrative and ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... Body Shaping" at the 2016 Anti-Aging & Beauty Awards at The ... The Aesthetic & Anti-Aging Medicine European Congress (AMEC) brings together the industry’s ...
(Date:12/4/2016)... ... December 04, 2016 , ... Are You Concerned About Mold In Your Home ... Indoor Air Quality Companies in VA, MD and DC, recently completed its application for ... new mold law in the district of Columbia is a good thing stated John ...
(Date:12/2/2016)... ... 2016 , ... Two years ago, Arizona State University students ... by 1 million viewers and won numerous honors, including the region’s top Emmy ... Walter Cronkite School of Journalism and Mass Communication are following up their award-winning ...
(Date:12/2/2016)... ... December 02, 2016 , ... Advanced Inc., a leading provider of ... Bice, CPA, MBA to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, ... Jason brings extensive financial and operational leadership experience to Advanced Inc. He began his ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... the ECG Cables And ECG Leadwires Market owing to the ... On the other hand, the Asia-Pacific ... during the forecast period. The market players namely, ... ( Ireland ), Koninklijke Philips N.V. ( ... China ), held major share of the ECG ...
(Date:12/2/2016)... 2, 2016 According to the latest ... Study on Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors ... Between 2016 and 2024 " the global automated endoscope reprocessors market was valued ... expand at a CAGR of 7.2% during an eight-year forecast ... Mn by 2024. ...
(Date:12/2/2016)... , December 2, 2016 ... Vitro Diagnostics/IVD Market by Product (Instruments, Reagents, Software), ... (Diabetes, Oncology, Cardiology, Nephrology, Infectious Diseases) - Forecast ... is valued at USD 60.22 Billion in 2016. ... CAGR of 5.5% during the forecast period (2016-2021) ...
Breaking Medicine Technology: